Physician

Andrea Katz, M.D.

According to 2025 Medicare claims, Andrea Katz, M.D. (NPI: 1295927739) practices medical oncology in the Deltona-Daytona Beach-Ormond Beach, FL market, with the plurality of this provider's patient population coming from Volusia, FL. This provider's primary affiliated billing organization is FLORIDA HOSPITAL MEDICAL GROUP INC (NPI: 1225034234; TIN: 593214635) and primary practice location at 32168-7325.

Katz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 325 traditional Medicare patients, billed 17,804 HCPCS/CPT codes, and received $188,069 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 263 prescription claims across 100 beneficiaries totaling $385,452 in drug costs, led by Eliquis (Apixaban). 2016 DME data shows 49 claims. Open Payments data shows 11 records totaling $240. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $686,160 and ending at $188,069. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $212,964 to $385,452. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	333	48,517	$686,160
2016	269	1,622	$105,388
2017	172	12,667	$176,186
2018	186	79,539	$884,074
2019	222	67,734	$882,779
2020	229	138,855	$1,332,753
2021	283	97,868	$1,576,591
2022	344	132,227	$1,583,143
2023	390	84,838	$714,763
2024	325	17,804	$188,069

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	79	634	$212,964
2016	65	293	$400,989
2017	85	268	$629,059
2018	101	502	$681,721
2019	125	572	$1,325,039
2020	127	643	$1,459,626
2021	125	692	$2,170,339
2022	137	699	$2,528,928
2023	119	529	$2,138,638
2024	100	263	$385,452

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	26	124	$9,178
2016	N/R	49	$14,483
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	65	65	$147
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	133	293	$82
36415	Insertion of needle into vein for collection of blood sample	98	121	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	101	131	$8
96372	Injection of drug or substance under skin or into muscle	51	78	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	36	1,230	$24,071
Ondansetron Odt	Ondansetron	16	390	$897
Prochlorperazine Maleate	Prochlorperazine Maleate	26	332	$494
Letrozole	Letrozole	11	750	$284
Dexamethasone	Dexamethasone	11	328	$238

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$240	Fennec Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrea Katz, M.D.?

Tedicare shows public-source Medicare data for Andrea Katz, M.D. (NPI 1295927739), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrea Katz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrea Katz, M.D.?

Andrea Katz, M.D. is linked to FLORIDA HOSPITAL MEDICAL GROUP INC (billing NPI 1225034234) in the available physician profile data.

Does Andrea Katz, M.D. have Open Payments data?

Andrea Katz, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.